{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:48:41Z","timestamp":1795085321291,"version":"4.10.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1245\/s10434-020-09226-7","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:02:58Z","timestamp":1602864178000},"page":"3258-3263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Role of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.1245","volume":"28","author":[{"given":"Claudia","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Tombolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"9226_CR1","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jamaoncol.2018.2761","volume":"4","author":"RL Dood","year":"2018","unstructured":"Dood RL, Zhao Y, Armbruster SD, et al. Defining survivorship trajectories across patients with solid tumors: an evidence-based approach. JAMA Oncol. 2018;4:1519\u201326. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2761.","journal-title":"JAMA Oncol."},{"key":"9226_CR2","unstructured":"National Comprehensive Cancer Network (NCCN) Guidelines for ovarian cancer including fallopian tube cancer and primary peritoneal cancer, version 1.2020. http:\/\/www.nccn.org. Accessed 10 June 2020."},{"key":"9226_CR3","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","volume":"381","author":"RL Coleman","year":"2019","unstructured":"Coleman RL, Spirtos NM, Enserro D, et al. Secondary surgical cytoreduction for recurrent ovarian cancer. N Engl J Med. 2019;381:1929\u201339. https:\/\/doi.org\/10.1056\/nejmoa1902626.","journal-title":"N Engl J Med."},{"key":"9226_CR4","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1200\/JCO.2017.35.15_suppl.5501","volume":"35","author":"A Du Bois","year":"2020","unstructured":"Du Bois A, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, et al. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20. J Clin Oncol. 2020;35:5501.","journal-title":"J Clin Oncol."},{"key":"9226_CR5","doi-asserted-by":"crossref","unstructured":"Zang R, Zhu J, Shi T, Liu J, Tu D, Yin S, et al. A randomized phase\u00a0III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1\/SGOG-OV2. J Clin Oncol. 2020;38:6001 (https:\/\/meetinglibrary.asco.org\/record\/185448\/video).","DOI":"10.1200\/JCO.2020.38.15_suppl.6001"},{"key":"9226_CR6","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006\u201312.","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"9226_CR7","doi-asserted-by":"publisher","first-page":"101945","DOI":"10.1016\/j.ctrv.2019.101945","volume":"83","author":"C Marchetti","year":"2020","unstructured":"Marchetti C, Fagotti A, Tombolini V, Scambia G, De Felice F. Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: a systematic review and meta-analysis. Cancer Treat Rev. 2020;83:101945.","journal-title":"Cancer Treat Rev."},{"key":"9226_CR8","doi-asserted-by":"crossref","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction: GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394.","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"9226_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","volume":"13","author":"C Tufanaru","year":"2015","unstructured":"Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthcare. 2015;13:196\u2013207.","journal-title":"Int J Evid Based Healthcare."},{"key":"9226_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ."},{"key":"9226_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000159266","volume":"75","author":"A Fagotti","year":"2008","unstructured":"Fagotti A, Fanfani F, Rossitto C, et al. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy. Oncology. 2008;75:152\u20138.","journal-title":"Oncology."},{"key":"9226_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ygyno.2017.02.010","volume":"145","author":"RA Cowan","year":"2017","unstructured":"Cowan RA, Eriksson AGZ, Jaber SM, et al. A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2017;145:230\u20135.","journal-title":"Gynecol Oncol."},{"key":"9226_CR13","unstructured":"FDA Label for Olaparib. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/208558s006lbl.pdf. Accessed 10 June 2020."},{"key":"9226_CR14","unstructured":"National Comprehensive Cancer Network.\u00a0Ovarian cancer including fallopian tube cancer and primary peritoneal cancer.\u00a0NCCN Clin Pract Guidelines Oncol. 2014;3:1\u201390."},{"key":"9226_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ygyno.2019.10.023","volume":"156","author":"SC Cecere","year":"2020","unstructured":"Cecere SC, Giannone G, Salutari V, et al. Olaparib as maintenance therapy in patients with BRCA 1\u20132 mutated recurrent platinum-sensitive ovarian cancer: real world data and post progression outcome.\u00a0Gynecol Oncol. 2020;156:38\u201344.","journal-title":"Gynecol Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09226-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T11:18:35Z","timestamp":1634383115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09226-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9226"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09226-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}